4.2 Article

Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Journal

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Volume 42, Issue 7, Pages 1327-1341

Publisher

WILEY
DOI: 10.1111/acer.13769

Keywords

Fetal Alcohol Spectrum Disorders; Fetal Alcohol Syndrome; Prenatal Alcohol Exposure; Choline Supplementation; Eyeblink Conditioning; Growth

Funding

  1. NIH/National Institute on Alcohol Abuse and Alcoholism [R21AA020332, R01AA016781, K23AA020516]
  2. National Institute of Diabetes and Digestive and Kidney Diseases [R01DK115380, P30DK056350, K24DK104676, 2P30DK040561]
  3. Lycaki-Young Fund of Michigan

Ask authors/readers for more resources

BackgroundWe recently demonstrated the acceptability and feasibility of a randomized, double-blind choline supplementation intervention for heavy drinking women during pregnancy. In this study, we report our results relating to the efficacy of this intervention in mitigating adverse effects of prenatal alcohol exposure (PAE) on infant growth and cognitive function. MethodsSixty-nine Cape Coloured (mixed ancestry) heavy drinkers in Cape Town, South Africa, recruited in mid-pregnancy, were randomly assigned to receive a daily oral dose of either 2g of choline or placebo from time of enrollment until delivery. Each dose consisted of an individually wrapped packet of powder that, when mixed with water, produced a sweet tasting grape-flavored drink. The primary outcome, eyeblink conditioning (EBC), was assessed at 6.5months. Somatic growth was measured at birth, 6.5, and 12months, recognition memory and processing speed on the Fagan Test of Infant Intelligence, at 6.5 and 12months. ResultsInfants born to choline-treated mothers were more likely to meet criterion for conditioning on EBC than the placebo group. Moreover, within the choline arm, degree of maternal adherence to the supplementation protocol strongly predicted EBC performance. Both groups were small at birth, but choline-treated infants showed considerable catch-up growth in weight and head circumference at 6.5 and 12months. At 12months, the infants in the choline treatment arm had higher novelty preference scores, indicating better visual recognition memory. ConclusionsThis exploratory study is the first to provide evidence that a high dose of choline administered early in pregnancy can mitigate adverse effects of heavy PAE on EBC, postnatal growth, and cognition in human infants. These findings are consistent with studies of alcohol-exposed animals that have demonstrated beneficial effects of choline supplementation on classical conditioning, learning, and memory.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available